当前位置：
X-MOL 学术
›
Clin. Exp. Allergy
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A hybrid of two major Blomia tropicalis allergens as an allergy vaccine candidate
Clinical & Experimental Allergy ( IF 6.1 ) Pub Date : 2020-05-13 , DOI: 10.1111/cea.13611 Eduardo Santos da Silva 1, 2, 3 , Lorenz Aglas 3 , Carina Silva Pinheiro 1 , Emília M M de Andrade Belitardo 1, 4 , Elisânia Fontes Silveira 1 , Sara Huber 3 , Rogério Tanan Torres 1 , Michael Wallner 3 , Peter Briza 3 , Peter Lackner 3 , Josef Laimer 3 , Luis Gustavo C Pacheco 1 , Álvaro A Cruz 5 , Neuza Maria Alcântara-Neves 1, 2, 4 , Fatima Ferreira 3
Clinical & Experimental Allergy ( IF 6.1 ) Pub Date : 2020-05-13 , DOI: 10.1111/cea.13611 Eduardo Santos da Silva 1, 2, 3 , Lorenz Aglas 3 , Carina Silva Pinheiro 1 , Emília M M de Andrade Belitardo 1, 4 , Elisânia Fontes Silveira 1 , Sara Huber 3 , Rogério Tanan Torres 1 , Michael Wallner 3 , Peter Briza 3 , Peter Lackner 3 , Josef Laimer 3 , Luis Gustavo C Pacheco 1 , Álvaro A Cruz 5 , Neuza Maria Alcântara-Neves 1, 2, 4 , Fatima Ferreira 3
Affiliation
Allergen‐specific immunotherapy (AIT) represents a curative approach for treating allergies. In the tropical and subtropical regions of the world, Blomia tropicalis (Blo t 5 and Blo t 21) is the likely dominant source of indoor allergens.
中文翻译：
两种主要热带布洛米亚过敏原的混合体作为过敏疫苗候选者
过敏原特异性免疫疗法 (AIT) 代表了一种治疗过敏的治疗方法。在世界的热带和亚热带地区，热带木虱（Blo t 5 和 Blo t 21）可能是室内过敏原的主要来源。
更新日期：2020-05-13
中文翻译：
两种主要热带布洛米亚过敏原的混合体作为过敏疫苗候选者
过敏原特异性免疫疗法 (AIT) 代表了一种治疗过敏的治疗方法。在世界的热带和亚热带地区，热带木虱（Blo t 5 和 Blo t 21）可能是室内过敏原的主要来源。
京公网安备 11010802027423号